Ipatasertib plus paclitaxel for PIK3CA/AKT1/PTEN-altered hormone receptor-positive HER2-negative advanced breast cancer: primary results from cohort B of the IPATunity130 randomized phase 3 trial
暂无分享,去创建一个
Sung-Bae Kim | I. Bondarenko | C. Barrios | J. O’Shaughnessy | N. Turner | S. Isakoff | M. Wongchenko | Z. Nowecki | R. Dent | Mafalda Oliveira | S. Saji | Heather Hinton | A. Mani | S. Reilly | Q. Lian | Bruno Kovic | B. Kovic | H. Hinton